Septerna (SEPN) Change in Account Payables (2023 - 2026)
Septerna (SEPN) recorded quarterly Change in Account Payables of -$2.3 million in Q1 2026, down 137.91% quarter-over-quarter from $6.1 million in Q4 2025, and down 294.1% on a YoY basis from $1.2 million in Q1 2025.
Septerna (SEPN) Change in Account Payables (2023 - 2026) Analysis & Trends
Septerna's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 294.1% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at $3.1 million (up 51.8% YoY), while the FY2025 annual figure was $6.6 million, up 813.28% from the prior year.
- Change in Account Payables was -$2.3 million for Q1 2026 at Septerna, down from $6.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.1 million in Q4 2025 to a low of -$2.9 million in Q3 2025.
- Historically, Change in Account Payables has averaged $550200.0 across 4 years, with a median of $167500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables slumped 454.81% in 2024, then surged 1214.21% in 2025.
- A 4-year view of Change in Account Payables shows it stood at $478000.0 in 2023, then plunged by 454.81% to -$1.7 million in 2024, then jumped by 458.08% to $6.1 million in 2025, then slumped by 137.91% to -$2.3 million in 2026.
- The last three Change in Account Payables figures came in at -$2.3 million (Q1 2026), $6.1 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.30 Mn |
| Mar 31, 2026 | -2.30 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | -2.85 Mn |
| Sep 30, 2025 | -2.85 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | -197,000.00 |
| Jun 30, 2024 | -197,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Dec 31, 2023 | 478,000.00 |
| Dec 31, 2023 | 478,000.00 |